Magnetic resonance-guided focused ultrasound therapy for symptomatic uterine fibroids

Technol Eval Cent Assess Program Exec Summ. 2005 Oct;20(10):1-3.
No abstract available

MeSH terms

  • Blue Cross Blue Shield Insurance Plans
  • Device Approval
  • Female
  • Humans
  • Leiomyoma / therapy*
  • Magnetic Resonance Imaging*
  • Technology Assessment, Biomedical
  • Treatment Outcome
  • Ultrasonic Therapy*
  • United States
  • United States Food and Drug Administration
  • Uterine Neoplasms / therapy*